McCann Health Appoints Linda Szyper as Global Chief Operating Officer

McCann Health has announced the appointment of Linda Szyper to the new position of Global Chief Operating Officer. This appointment follows a year of dynamic growth through the addition of new assignments and expanded relationships with existing clients such as GlaxoSmithKline, Bayer, Gilead and Janssen among others.

In this role, Linda will work closely with John Cahill, McCann Health Global CEO, and the global leadership team to optimise the operations of the company’s global network to accommodate the rapid growth objectives of the organisation. 

“Linda brings with her a wealth of experience in driving both efficiency and effectiveness across diverse healthcare groups,” said Cahill. “These skills and her incredible experience in global healthcare communications will complement and enhance the McCann Health global leadership team and deliver real benefit to our growing roster of clients.”

“I’m excited to be joining McCann Health, one of the fastest-growing businesses in the industry, at a such a significant time in their history,” said Szyper. “I look forward to maximising the operating efficiencies across the global network on behalf of clients and to help take the company to even greater heights.“

Linda has more than 30 years’ experience in healthcare marketing, communications and product commercialisation and has held a number of senior-level roles in major pharmaceutical and communication companies.

Most recently, Linda was the Chief Commercial Officer and President of US Operations for Circassia Pharmaceuticals, a speciality pharmaceutical company focused on respiratory diseases. Prior to Circassia, Ms. Szyper held the role of Chief Development Officer at Publicis Healthcare Group, where she was responsible for the development and advancement of the various healthcare communication businesses worldwide.  

Prior to this, as President of the Publicis Medical Education Group, Linda led a number of agencies in providing a broad range of strategic product commercialisation support to many of the top pharmaceutical organisations.  Previously, she held senior leadership roles in marketing and commercial development in the pharmaceutical industry, including Vice President of Sales and Marketing for Serono’s Reproductive and Women’s Health business in the US, and Senior Director, Global Commercialisation for Searle’s Cardiovascular Portfolio.  

She holds a Masters of Business Administration Degree from Kellstadt Graduate School of Business (DePaul University) and a Bachelor of Science in Biomedical Engineering from Northwestern University.